ARCHIVES

Coalition Gives “Incomplete” To NCI, CDC Statistics, But Gets Low Grade From Critics

This article is from The Cancer Letter archive.

Vol. 24 No. 11 | March 20, 1998

Download PDF Visit The Full Archive

Related Articles

Bill Would Harm Pancreatic Cancer Research – Scientists Warn Of Unintended Consequences

August 10, 2012

(8-page issue)

November 2, 2002

DCE Reorganization Planned To Stem Departures, Stabilize

March 24, 1995

An old drug’s 21st century makeover begins with 84-fold price increase. Price hike of procarbazine astonishes brain tumor specialists.

May 13, 2005

Congress Reaffirms GRH FY 1986 Cuts

July 25, 1986

NCI Sends A Second Letter To Groups About Carboplatin

October 22, 2010